Clinical Trials Access Collaborative (CTAC)
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at Clinical Trials Access Collaborative (CTAC)
Tesheia Harris
Chief Executive Officer
Clinical Trials Access Collaborative (CTAC) Email Formats
Clinical Trials Access Collaborative (CTAC) uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@ctac.org), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@ctac.org | 100% |
About Clinical Trials Access Collaborative (CTAC)
Clinical Trials Access Collaborative (CTAC) is a partnership committed to making medical research more accessible. Clinical trials are a crucial component to advancing medical research and improving patient outcomes. By expanding participation in clinical trials, communities across the U.S. will have the opportunity to participate in and benefit from the latest advancements in treatment while improving medical research. * CTAC presently is in the 501(c)(3) application process.
Clinical Trials Access Collaborative (CTAC) revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Clinical Trials Access Collaborative (CTAC) has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Clinical Trials Access Collaborative (CTAC) has never raised funding before.
Czechia
Canada
United Kingdom
Sweden
South AfricaFrequently asked questions
4.8
40,000 users
